S
Suzhen Wang
Researcher at University of Texas MD Anderson Cancer Center
Publications - 7
Citations - 841
Suzhen Wang is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Medicine & Immune system. The author has an hindex of 1, co-authored 1 publications receiving 652 citations.
Papers
More filters
Journal ArticleDOI
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Krishna P.L. Bhat,Veerakumar Balasubramaniyan,Brian Vaillant,Ravesanker Ezhilarasan,Karlijn Hummelink,Faith Hollingsworth,Khalida Wani,Lindsey Heathcock,Johanna D. James,Lindsey D. Goodman,Siobhan Conroy,Lihong Long,Nina Lelic,Suzhen Wang,Joy Gumin,Divya Raj,Yoshinori Kodama,Aditya Raghunathan,Adriana Olar,Kaushal Joshi,Christopher E. Pelloski,Amy B. Heimberger,Se Hoon Kim,Daniel P. Cahill,Ganesh Rao,Wilfred F. A. den Dunnen,Hendrikus Boddeke,Heidi S. Phillips,Ichiro Nakano,Frederick F. Lang,Howard Colman,Erik P. Sulman,Kenneth Aldape +32 more
TL;DR: It is shown that patient-derived glioma sphere cultures that resemble either the proneural (PN) or mesenchymal (MES) transcriptomal subtypes differ significantly in their biological characteristics, and it is suggested that the tumor microenvironment cell types such as macrophages/microglia may play an integral role in this process.
Journal ArticleDOI
Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma
Wenjing Zhang,Yujia Kong,Yuting Li,Fuyan Shi,Juncheng Lyu,Chao Sheng,Suzhen Wang,Qinghua Wang +7 more
TL;DR: Several novel SMGs and re-annotated mutational signatures that are linked to immunotherapy response or resistance and an immune subtype was found to exhibit favorable prognoses, and further studies are required to validate these findings.
Journal ArticleDOI
Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations
Wenjing Zhang,Yunfeng Tang,Yuxian Guo,Yujia Kong,Fuyan Shi,Chao Sheng,Suzhen Wang,Qinghua Wang +7 more
TL;DR: Wang et al. as discussed by the authors investigated the association of atypical cadherin 1 (FAT1) mutations with ICI response and outcome and found that patients with FAT1 mutations had a significantly improved survival outcome than those wild-type patients.
Journal ArticleDOI
HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer
Wenjing Zhang,Zhijuan Lin,Fuyan Shi,Qian Wang,Yujia Kong,Yanfeng Ren,Juncheng Lyu,Chao Sheng,Yuting Li,Hao Qin,Suzhen Wang,Qinghua Wang +11 more
TL;DR: It is uncovered that HSPG2 mutations were predictive of a better ICI response and associated with preferable immunogenicity, which may be considered as a genomic determinant to customize biotherapy strategies.
Journal ArticleDOI
Bioinformatic analysis identifies the immunological profile of turner syndrome with different X chromosome origins
TL;DR: In this paper , the authors investigated the immunological characteristics of Turner syndrome (TS) patients with different X-chromosomal origins and found that the most enriched signals were immune response-related.